Bioharvest Sciences, Inc. (TSE:BHSC) has released an update.
Bioharvest Sciences Inc., a leader in botanical synthesis technology, announced its participation in the Benzinga Virtual Healthcare Summit on March 20, 2024, where CEO Ilan Sobel will discuss the company’s recent milestones and provide a corporate update. The event will cover a range of topics within the healthcare sector and is expected to attract key industry players, analysts, and thought leaders. Bioharvest is known for its innovative approach to producing plant-based molecules without the need to grow the underlying plant, serving both as a CDMO and creator of nutraceutical products.
For further insights into TSE:BHSC stock, check out TipRanks’ Stock Analysis page.
